Opinion on Oncology in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Cancer: launch of angiogenesis inhibitors will increase treatment options

Published By Datamonitor
25 May 2001
ResearchWire
ResearchWire

Leukemia: only 54% of Spaniards first present to PCP

Published By Datamonitor
31 May 2001
ResearchWire
ResearchWire

Cytotoxic antibiotics: sales down 4% by 2007

Published By Datamonitor
11 Jun 2001
CommentWire
CommentWire

Novartis: a small setback for Gleevec

Published By Datamonitor
25 Jun 2001
CommentWire
CommentWire

Debiopharm: a bleak future for Trelstar

Published By Datamonitor
09 Jul 2001
ResearchWire
ResearchWire

Gastric cancer: incidence falling, prevalence rising

Published By Datamonitor
08 Aug 2001
CommentWire
CommentWire

Novuspharma: lymphoma drug well positioned for success

Published By Datamonitor
01 Oct 2001
CommentWire
CommentWire

Roche: Xeloda gets warning on warfarin interaction

Like many drugs, and some foods, Xeloda interacts negatively with popular anticoagulant warfarin. This may reduce the use of Xeloda in cancer patients requiring anticoagulation. It also highlights the potential of AstraZeneca's new oral anticoagulant, ximelagatran, which is currently undergoing phase III trials and is not associated with the interactions that plague warfarin.

Published By Datamonitor
07 Nov 2001
CommentWire
CommentWire

Inex/GSK: the growing importance of drug delivery

GSK will foot the bill for Inex's development work. In a market where drug delivery is becoming as important as the compound itself, the deal represents a good chance for GSK to boost the sales and life expectancy of its drug. Inex, meanwhile, should gain significant opportunities by partnering with a leading pharmaceutical company.

Published By Datamonitor
26 Nov 2001
ResearchWire
ResearchWire

Gastric cancer: 10 times more common in Japan than US

Published By Datamonitor
05 Dec 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.